Virtus LifeSci Selected Fundamentals

Virtus LifeSci Biotech Clinical Trls ETF -- USA Etf  

USD 32.48  0.60  1.88%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools

Price to Earning Analysis

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investor monitor on a daily basis. Holding a low PE stock is less risky because. When a company's profitability fall, it is likely that earnings will also go down..In other words, if you start from a lower position your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Virtus LifeSci 
P/E 
 = 
Market Value Per Share 
Earnings Per Share 
 = 
39.87 times

About Price to Earning

Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Compare to competition
Based on latest financial disclosure the price to earning indicator of Virtus LifeSci Biotech Clinical Trls ETF is roughly 39.87 times. This is much higher than that of the BioShares family, and significantly higher than that of Sector category, The Price to Earning for all etfs is over 1000% lower than the firm.

Virtus LifeSci Biotech Fundamental Drivers Relationships

Virtus LifeSci Biotech Clinical Trls ETF is rated below average in price to book as compared to similar ETFs. It is second largest ETF in price to earning as compared to similar ETFs reporting about  22.78  of Price to Earning per Price to Book.

Peer Comparison

Virtus LifeSci Price to Sales Comparison
  Price to Sales 
      Virtus LifeSci Comparables 
Virtus LifeSci is currently under evaluation in price to sales as compared to similar ETFs.

Did you try this?

Run Cryptocurrency Center Now
   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
View All  NextLaunch Cryptocurrency Center

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Asset Allocation

Fund Instrument Allocation for Virtus LifeSci
The fund invests 99.63% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.
 Value 
      Instrument Type 

Fundamental Indicators

Current Virtus LifeSci financial ratios